Font Size: a A A
Keyword [Solid Tumor]
Result: 101 - 120 | Page: 6 of 7
101. DPP4 Inhibitor Enhances The Infiltration Of CAR-T Cells To Solid Tumor
102. Mechanism Investigation Of Tumor Microenvironment Response Multistage Nanoparticles For Deep Tumor Penetration
103. Correlation Between Immune Related Adverse Events With Clinical Efficacy In Solid Tumors Treated With Immune Checkpoint Inhibitors
104. Antibody carriers of CpG oligodeoxynucleotides for solid tumor immunotherapy
105. Lymphatic pump treatment enhances pulmonary immunity and inhibits solid tumor formation in the lun
106. The role of VEGF autocrine signaling in hypoxia and oxidative stress driven 'stemness switch': Implications in solid tumor progression and metastasis
107. Pet Imaging of Early Therapeutic Response in Solid Tumor
108. Characterization and enhancement of interstitial gene transport during electric field-mediated gene delivery to solid tumor
109. Antibody-mediated systemic delivery of CpG oligodeoxynucleotides for solid tumor immunotherapy
110. Detection of circulating tumor cells in the peripheral blood of solid tumor patients
111. Developing vascular and hypoxia based theranostics in solid tumor
112. The development and evaluation of systemic drug delivery systems for C6-ceramide as a breast cancer chemotherapeutic agent
113. Modeling solid tumor growth in complex, dynamic geometries
114. Multiscale models of solid tumor growth: From the cell-level to the continuum
115. The essential roles of HIF-1alpha and VHL in endothelial cells during development and solid tumor formation
116. PEGylated carboxypeptidase A for solid tumor targeting
117. Experimental chemotherapeutic approaches in solid tumor spheroids of gastro-intestinal cell lines using the chemotherapeutic drug gemcitabine-HCl (Gemzar(TM)) and the cyclooxygenase inhibitor rofecoxib (Vioxx(TM))
118. Therapeutic Effect And Mechanism Of ATP Responsive Cationic Polymer Gene Vector On Solid Tumor
119. Construction Of A Pan-Solid Tumor-Associated Antigen Atlas And Its Application To Antibody-Drug Conjugates And Chimeric Antigen Receptor T Cells
120. Normal Reference Range Of Peripheral Blood Lymphocyte Subsets In Different Age Groups Of Healthy Chinese Adults And Its Preliminary Clinical Application
  <<First  <Prev  Next>  Last>>  Jump to